Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more) Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Spectral Medical Inc > New Press Release - Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(275)
•••
Comment by palinc2000on Mar 28, 2024 5:00pm
124 Views
Post# 35959099

RE:RE:RE:New Press Release - Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

RE:RE:RE:New Press Release - Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate UpdateI still cannot get over the fact that they agreed to accept a meager 2 million cad  dollrs to grant exclusive  marketing rights to Baxter ,,,,,especially considering that ,,,,,results were exceeding expectations  and that they dont have enough cash to last more than ???

JohnnyCashMoney wrote: He is still patting himself on the back for increasing sites and decreasing enrolment 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities